Literature DB >> 6356363

Metallothionein-human GH fusion genes stimulate growth of mice.

R D Palmiter, G Norstedt, R E Gelinas, R E Hammer, R L Brinster.   

Abstract

The promoter or regulatory region of the mouse gene for metallothionein-I was fused to the structural gene coding for human growth hormone. These fusion genes were introduced into mice by microinjection of fertilized eggs. Twenty-three (70 percent) of the mice that stably incorporated the fusion genes showed high concentrations of human growth hormone in their serum and grew significantly larger than control mice. Synthesis of human growth hormone was induced further by cadmium or zinc, which normally induce metallothionein gene expression. Transgenic mice that expressed human growth hormone also showed increased concentrations of insulin-like growth factor I in their serum. Histology of their pituitaries suggests dysfunction of the cells that normally synthesize growth hormone. The fusion genes were expressed in all tissues examined, but the ratio of human growth hormone messenger RNA to endogenous metallothionein-I messenger RNA varied among different tissues and different animals, suggesting that expression of the foreign genes is influenced by site of integration and tissue environment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356363     DOI: 10.1126/science.6356363

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  126 in total

1.  Expression of heat shock-regulated human growth hormone genes containing or lacking introns by NIH-3T3 and Wish cell lines.

Authors:  S Alouani; P L'Hote; J B Marq; L M Houdebine; F Montandon; M Chessebeuf-Padieu; M Dreano
Journal:  Cell Biol Toxicol       Date:  1992 Apr-Jun       Impact factor: 6.691

Review 2.  The concept of space and competition in immune regulation.

Authors:  Brigitta Stockinger; Thomas Barthlott; George Kassiotis
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

3.  Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice.

Authors:  M K Short; D E Clouthier; I M Schaefer; R E Hammer; M A Magnuson; E G Beale
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

4.  Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals.

Authors:  X M Cao; R A Koski; A Gashler; M McKiernan; C F Morris; R Gaffney; R V Hay; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

5.  Over-expression of Adamts1 in mice alters bone mineral density.

Authors:  Lijuan Hu; Kenneth B Jonsson; Harriet Andersén; Anne Edenro; Mohammad Bohlooly-Y; Håkan Melhus; Thomas Lind
Journal:  J Bone Miner Metab       Date:  2011-10-15       Impact factor: 2.626

6.  Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.

Authors:  D Murphy; A Bishop; G Rindi; M N Murphy; G W Stamp; J Hanson; J M Polak; B Hogan
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

7.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Methylation and expression of a metallothionein promoter ovine growth hormone fusion gene (MToGH1) in transgenic mice.

Authors:  K J Snibson; D Woodcock; J M Orian; M R Brandon; T E Adams
Journal:  Transgenic Res       Date:  1995-03       Impact factor: 2.788

9.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Authors:  Vijay Pandey; Jo K Perry; Kumarasamypet M Mohankumar; Xiang-Jun Kong; Shu-Min Liu; Zheng-Sheng Wu; Murray D Mitchell; Tao Zhu; Peter E Lobie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 10.  The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.

Authors:  Robert H Mak; Wai W Cheung; Charles T Roberts
Journal:  Growth Horm IGF Res       Date:  2007-09-07       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.